Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07318363 · ClinicalTrials.gov registry record · Phase 3
IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention
A Phase 3 study, sponsored by M.D. Anderson Cancer Center.
- Not yet
- Registry status
- Phase 3
- Development phase
- 2,100
- Enrollment target
NCT07318363: Clinical Trial Phase 3 study, sponsored by M.D. Anderson Cancer Center.
NCT07318363 is a Phase 3 study that has not yet begun recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07318363, a Phase 3 study, has not yet begun recruiting, sponsored by M.D. Anderson Cancer Center.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 2,100 participants
- Enrollment target
Study Summary
This trial aims to implement and compare an evidence- and theory-based intervention strategy (IGNITE-TX Intervention) to support probands and their ARRs in family communication, informed decision-making, and navigation to CGT with standard of care, free genetic testing/counseling, and intervention with free genetic testing/counseling.
Interventions
- OTHER IGNITE-TX program
- OTHER Genetic Counseling and Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,100 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2032-04-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07318363
The ClinicalTrials.gov registry entry for NCT07318363 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 2,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IGNITE-TX program is the first listed.
NCT07318363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07318363 about?
NCT07318363 is a clinical study titled "IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention". This trial aims to implement and compare an evidence- and theory-based intervention strategy (IGNITE-TX Intervention) to support probands and their ARRs in family communication, informed decision-making, and navigation to CGT with standard of care, free genetic testing/counseling, and intervention w...
What is the current status of trial NCT07318363?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 2,100 participants. The study started on 2026-06-01. Estimated completion is 2032-04-01.
What interventions are being tested in trial NCT07318363?
The interventions under investigation include: IGNITE-TX program (OTHER), Genetic Counseling and Testing (OTHER).
Who is sponsoring clinical trial NCT07318363?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.